v3.26.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2025
Stockholders' Equity  
Summary of stock option activity

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted- 

  ​ ​ ​

Average 

Weighted- 

Remaining 

Number of 

Average 

Contractual Life 

Aggregate 

Options

Exercise Price

(in years)

Intrinsic Value

Outstanding at January 1, 2024

 

15,417,986

$

5.90

6.9

$

15,854

Granted

 

1,922,756

$

4.36

 

  ​

 

  ​

Exercised

 

(1,191,117)

$

1.34

 

  ​

$

3,402

Forfeited

 

(2,093,840)

$

7.64

 

  ​

 

  ​

Outstanding at December 31, 2024

 

14,055,785

$

5.82

 

6.5

$

8,467

Granted

 

2,427,276

$

3.15

 

  ​

 

  ​

Exercised

 

(338,419)

$

1.28

 

  ​

$

906

Forfeited

 

(2,573,763)

$

5.94

 

  ​

 

  ​

Outstanding at December 31, 2025

 

13,570,879

$

5.44

 

5.9

$

76

Exercisable at December 31, 2025

 

10,978,477

$

5.90

 

5.3

$

76

Schedule of restricted stock unit activity

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted- 

  ​ ​ ​

Average 

Weighted-

Remaining 

Number of 

Average 

Amortization Period

RSUs

Grant Date Fair Value

(in years)

Outstanding at January 1, 2024

1,296,180

$

4.57

2.8

Granted

1,280,473

$

4.36

Vested and released

(418,260)

$

4.84

Forfeited

(454,334)

$

4.48

Outstanding at December 31, 2024

1,704,059

$

4.36

2.6

Granted

1,792,076

$

2.93

Vested and released

(609,460)

$

4.43

Forfeited

(1,080,924)

$

3.83

Outstanding at December 31, 2025

1,805,751

$

3.24

2.5

Schedule of stock-based compensation expense

  ​ ​ ​

Year ended December 31, 

2025

  ​ ​ ​

2024

General and administrative

$

5,656

$

7,200

Sales and marketing

 

1,679

 

2,920

Research and development

 

1,878

 

2,963

Total

$

9,213

$

13,083